Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Peter W Atadja"'
Autor:
Jian Ding, Guo Li, Hejun Liu, Lulu Liu, Ying Lin, Jingyan Gao, Guoqiang Zhou, Lingling Shen, Mengxi Zhao, Yanyan Yu, Weihui Guo, Ulrich Hommel, Johannes Ottl, Jutta Blank, Nicola Aubin, Yi Wei, Hu He, David R. Sage, Peter W. Atadja, En Li, Rishi K. Jain, John A. Tallarico, Stephen M. Canham, Ying-Ling Chiang, He Wang
Publikováno v:
ACS Chemical Biology. 18:34-40
WD repeat domain 5 (WDR5) is a member of the WD40-repeat protein family that plays a critical role in multiple processes. It is also a prominent target for pharmacological inhibition in diseases such as cancer, aging, and neurodegenerative disorders.
Autor:
Nicole M. Haynes, Ricky W. Johnstone, Michael A. Henderson, Peter W. Atadja, Phillip K. Darcy, Mark J. Smyth, Joseph A. Trapani, Kelly M. Ramsbottom, Misty R. Jenkins, Jason Li, Stephin J Vervoort, Eva Vidacs, Mikolaj Medon
Supplemental Figure Legend, Supplementary Figure 1 Flow cytometric analysis of HER2 expression on AU565pv and BT474 tumor cells; Supplementary Figure 2 Co-treatment with panobinostat and trastuzumab does not alter splenic NK cell activation/maturatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758d74328141ea197061c01e5829a8ca
https://doi.org/10.1158/0008-5472.22413813
https://doi.org/10.1158/0008-5472.22413813
Supplementary Figures 1-2 from Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of γ-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bcfecff111ce9aa9a2f26746483092d
https://doi.org/10.1158/0008-5472.22366536.v1
https://doi.org/10.1158/0008-5472.22366536.v1
Histone deacetylases (HDAC) have been identified as therapeutic targets due to their regulatory function in DNA structure and organization. LBH589 is a novel inhibitor of class I and II HDACs. We studied the effect of LBH589 and ionizing radiation (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f0202b58a8b7b0e9b3cbad084d4abd
https://doi.org/10.1158/0008-5472.c.6495183.v1
https://doi.org/10.1158/0008-5472.c.6495183.v1
Autor:
Lawrence Quaye, Eric Agboli, Peter W Atadja, Robert Adeze-Kpodo, Gideon Kye-Duodu, Sylvester Yao Lokpo, Fred Binka
Publikováno v:
Asian Journal of Medicine and Health. 10:1-9
Publikováno v:
Expert Review of Anti-infective Therapy. 14:345-352
Disequilibrium in the human debilitated immune system favors proliferation of invasive Candida species, a major therapeutic challenge due to development of resistance to several conventional antifungal agents (CAA) worldwide. Multiple mutations obser